ArticleDermatology and therapy2026

Letter to the Editor Regarding "Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo Adjusted Indirect Treatment Comparison".

Raj Chovatiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.